Literature DB >> 20628542

Structural characterizations of an Re(IV) complex [ReCl(4)(OPPh(3))(2)] and of an imino species [ReOCl(2)(PPh(3))(eta-OC(6)H(4)-2-CH=NH)] prepared from the reaction of [ReOCl(3)(PPh(3))(2)] with salicylaldoxime.

Xiaoyuan Chen1, Frank J Femia, John W Babich, Jon Zubita.   

Abstract

The reaction of [ReOCl(3)(PPh(3))(2)] with salicylaldoxime unexpectedly yields [ReCl(4)(OPPh(3))(2)] (1) and [ReOCl(2)(PPh(3))(eta(2)-OC(6)H(4)-2-CH=NH)] (2). The crystal structure of the Re(IV) complex 1 consists of discrete mononuclear units. The Re site is bound to four chlorides and two trans oxygens of the OPPh(3) groups. The crystal structure of 2 is also mononuclear with the geometry of the Re(V) center defined by a terminal oxo-group, two cis chlorides, the phosphorus of the PPh(3), and the nitrogen and oxygen donors of the phenoxyimino ligand [OC(6)H(4)-2-CH=NH](-).

Entities:  

Year:  2000        PMID: 20628542      PMCID: PMC2901877          DOI: 10.1016/S0020-1693(00)00145-6

Source DB:  PubMed          Journal:  Inorganica Chim Acta        ISSN: 0020-1693            Impact factor:   2.545


  8 in total

1.  Therapeutic radiopharmaceuticals.

Authors:  W A Volkert; T J Hoffman
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

2.  Potential technetium small molecule radiopharmaceuticals.

Authors:  S S Jurisson; J D Lydon
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

3.  99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals.

Authors:  S Liu; D S Edwards
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

4.  Oxorhenium(V) complexes containing tridentate Schiff-base and monothiol coligands.

Authors:  Frank J Femia; Xiaoyuan Chen; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2000-04-20       Impact factor: 2.545

5.  Novel 99mTc aminobisthiolato/monothiolato "3 + 1" mixed ligand complexes: structure-activity relationships and preliminary in vivo validation as brain blood flow imaging agents.

Authors:  I C Pirmettis; M S Papadopoulos; E Chiotellis
Journal:  J Med Chem       Date:  1997-08-01       Impact factor: 7.446

Review 6.  Vehicles, chelators, and radionuclides: choosing the "building blocks" of an effective therapeutic radioimmunoconjugate.

Authors:  P A Schubiger; R Alberto; A Smith
Journal:  Bioconjug Chem       Date:  1996 Mar-Apr       Impact factor: 4.774

7.  Tc-99m-labeled tropanes as dopamine transporter imaging agents.

Authors:  S Meegalla; K Plössl; M P Kung; S Chumpradit; D A Stevenson; D Frederick; H F Kung
Journal:  Bioconjug Chem       Date:  1996 Jul-Aug       Impact factor: 4.774

8.  Tridentate ligands containing the SNS donor atom set as a novel backbone for the development of technetium brain-imaging agents.

Authors:  S G Mastrostamatis; M S Papadopoulos; I C Pirmettis; E Paschali; A D Varvarigou; C I Stassinopoulou; C P Raptopoulou; A Terzis; E Chiotellis
Journal:  J Med Chem       Date:  1994-09-30       Impact factor: 7.446

  8 in total
  1 in total

1.  The syntheses and structures of '3+2' and '2+2+1' oxorhenium mixed-ligand complexes employing 8-hydroxy-5-nitroquinoline as the bidentate N,O donor ligand.

Authors:  Xiaoyuan Chen; Frank J Femia; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2000-10-20       Impact factor: 2.545

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.